IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Rational Pharmacotherapy in Cardiology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.78

h-Index

2024-2025

 15

Rank

2024-2025

 22175

SJR

2024-2025

 0.185

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Rational Pharmacotherapy in Cardiology
Abbreviation Ration. Pharmacother. Cardiol.
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q4); Pharmacology (medical) (Q4)
h-index 15
Overall Rank/Ranking 22175
SCImago Journal Rank (SJR) 0.185
Impact Score 0.78
Publisher Stolichnaya Izdatelskaya Kompaniya
Country Russian Federation
ISSN 18196446, 22253653
Best Quartile Q4
Coverage History 2012-2024




About Rational Pharmacotherapy in Cardiology


Rational Pharmacotherapy in Cardiology is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q4); Pharmacology (medical) (Q4). It is published by Stolichnaya Izdatelskaya Kompaniya. The overall rank of Rational Pharmacotherapy in Cardiology is 22175. According to SCImago Journal Rank (SJR), this journal is ranked 0.185. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 15. The best quartile for this journal is Q4.

The ISSN of Rational Pharmacotherapy in Cardiology journal is 18196446, 22253653. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Rational Pharmacotherapy in Cardiology is cited by a total of 223 articles during the last 3 years (Preceding 2024).


Rational Pharmacotherapy in Cardiology Impact IF 2024-2025


The Impact IF 2024 of Rational Pharmacotherapy in Cardiology is 0.78, which is computed in 2025 as per its definition. Rational Pharmacotherapy in Cardiology IF is increased by a factor of 0.15 and approximate percentage change is 23.81% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Rational Pharmacotherapy in Cardiology Impact IF 2025 Prediction


Impact IF 2024 of Rational Pharmacotherapy in Cardiology is 0.78. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Rational Pharmacotherapy in Cardiology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.78
2023 0.63
2022 0.41
2021 0.50
2020 0.61
2019 0.41
2018 0.44
2017 0.51
2016 0.21
2015 0.15
2014 0.10

Rational Pharmacotherapy in Cardiology h-index


  Table Setting

Rational Pharmacotherapy in Cardiology has an h-index of 15. It means 15 articles of this journal have more than 15 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Rational Pharmacotherapy in Cardiology ISSN


The ISSN of Rational Pharmacotherapy in Cardiology is 18196446, 22253653. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Rational Pharmacotherapy in Cardiology Rank and SCImago Journal Rank (SJR)


The overall rank of Rational Pharmacotherapy in Cardiology is 22175. According to SCImago Journal Rank (SJR), this journal is ranked 0.185. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Rational Pharmacotherapy in Cardiology by Year


Year SJR
2025/2026 Coming Soon
2024 0.185
2023 0.17
2022 0.160
2021 0.152
2020 0.161
2019 0.146
2018 0.138
2017 0.126
2016 0.121
2015 0.120
2014 0.119

Ranking of Rational Pharmacotherapy in Cardiology by Year


Year Ranking
2025/2026 Coming Soon
2024 22175
2023 21771
2022 21339
2021 21046
2020 22152
2019 22091
2018 22668
2017 23980
2016 25189
2015 24922
2014 24634

Rational Pharmacotherapy in Cardiology Publisher


Table Setting

Rational Pharmacotherapy in Cardiology is published by Stolichnaya Izdatelskaya Kompaniya. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 2012-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Rational Pharmacotherapy in Cardiology is Ration. Pharmacother. Cardiol.. This abbreviation ('Ration. Pharmacother. Cardiol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Rational Pharmacotherapy in Cardiology


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q4); Pharmacology (medical) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Rational Pharmacotherapy in Cardiology?

Rational Pharmacotherapy in Cardiology latest impact IF is 0.78. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.78 (2024) and 0.10 (2014), respectively, in the last 11 years. Moreover, its average IS is 0.43 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology has an SJR (SCImago Journal Rank) of 0.185, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.185 in 2024 and the lowest being 0.119 in 2014. Furthermore, the average SJR of the Rational Pharmacotherapy in Cardiology over the previous 11-year period stands at 0.43.


What's the latest h-index of the Rational Pharmacotherapy in Cardiology?

The latest h-index of the Rational Pharmacotherapy in Cardiology is 15.


Who's the publisher of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology is published by the Stolichnaya Izdatelskaya Kompaniya, with its country of publication being the Russian Federation.


What's the current ranking of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology is currently ranked 22175 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 21046 in 2021 and its lowest position of 25189 in 2016.


What's the abbreviation or short name for the Rational Pharmacotherapy in Cardiology?

The standard ISO4 abbreviation for the Rational Pharmacotherapy in Cardiology is Ration. Pharmacother. Cardiol..


Is the "Rational Pharmacotherapy in Cardiology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Rational Pharmacotherapy in Cardiology is classified as a journal that the Stolichnaya Izdatelskaya Kompaniya publishes.


What's the scope or major areas of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology encompasses the following areas:

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology is assigned the following International Standard Serial Numbers (ISSN): 18196446, 22253653.


What's the best quartile of the Rational Pharmacotherapy in Cardiology?

The best quartile for the Rational Pharmacotherapy in Cardiology is Q4 (2024).


What's the coverage history of the Rational Pharmacotherapy in Cardiology?

The Rational Pharmacotherapy in Cardiology coverage history can be summarized as follows: 2012-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
Proceedings of the International Symposium on Power Semiconductor Devices and ICs conference and proceedings 9089 Institute of Electrical and Electronics Engineers Inc. 55 2.19
CESifo Economic Studies journal 17776 Oxford University Press 36 0.89
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Journal of Supply Chain Management journal 331 Wiley-Blackwell 119 9.76
Journal of Education and Work journal 8987 Brill Academic Publishers 47 2.08
Socialism and Democracy journal 27160 Taylor and Francis Ltd. 19 0.20
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
Studies in Continuing Education journal 4850 Routledge 44 3.35

Check complete list




Year wise Impact Score (IS) of Rational Pharmacotherapy in Cardiology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.78
2023 0.63
2022 0.41
2021 0.50
2020 0.61
2019 0.41
2018 0.44
2017 0.51
2016 0.21
2015 0.15
2014 0.10



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Nature Reviews Cardiology
Nature Research | United Kingdom

Journal of the American College of Cardiology
Elsevier Inc. | United States

Circulation
Lippincott Williams and Wilkins | United States

JAMA Cardiology
American Medical Association | United States

European Journal of Heart Failure
John Wiley and Sons Ltd | United Kingdom

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

JACC: Heart Failure
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation Research
Lippincott Williams and Wilkins | United States

Nature Cardiovascular Research
Springer | Germany

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All